NASDAQ : BCRX
BioCryst Pharmaceuticals, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 8.47 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.16B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
BioCryst Pharmaceuticals, Inc. (BCRX) reported revenue of 940.61M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 940.61M | 874.84M | 450.71M | 331.41M | 270.83M | 157.17M |
| Cost of Revenue | 212.69M | 183.16M | 185.71M | 216.47M | 259.89M | 216.07M |
| Gross Profit | 727.92M | 691.68M | 265.01M | 114.94M | 10.94M | -58.90M |
| Selling, General & Admin | 298.68M | 344.37M | 266.29M | 213.72M | 159.37M | 118.82M |
| Operating Expenses | 298.68M | 344.37M | 266.29M | 213.72M | 159.37M | 118.82M |
| Operating Income | 429.25M | 347.30M | -1.28M | -98.78M | -148.44M | -177.72M |
| Interest Expense | -75.29M | -78.87M | -98.52M | -108.24M | -99.09M | -59.29M |
| Interest & Investment Income | 9.82M | 10.67M | 14.75M | 15.78M | 5.13M | 61.00K |
| Currency Exchange Gain (Loss) | -288.00K | -152.00K | -641.00K | -1.04M | -1.98M | -695.00K |
| Other Non Operating Income (Expenses) | 7.32M | 8.52M | ||||
| EBT Excluding Unusual Items | 370.81M | 287.47M | -85.69M | -192.28M | -244.38M | -237.65M |
| Merger & Restructuring Charges | -44.64M | -6.31M | -1.26M | -3.38M | ||
| Gain (Loss) on Sale of Investments | 1.00K | |||||
| Gain (Loss) on Sale of Assets | 3.57M | 3.57M | ||||
| Asset Writedown | -1.55M | |||||
| Other Unusual Items | -13.16M | -17.33M | -29.02M | 55.84M | ||
| Pretax Income | -381.19M | 267.39M | -86.95M | -226.23M | -244.38M | -181.81M |
| Income Tax Expense | 3.49M | 3.53M | 1.93M | 310.00K | 2.73M | 2.25M |
| Net Income | -384.67M | 263.86M | -88.88M | -226.54M | -247.12M | -184.06M |
| Net Income to Common | -384.67M | 263.86M | -88.88M | -226.54M | -247.12M | -184.06M |
| Shares Outstanding (Basic) | 229.49M | 209.89M | 206.70M | 192.20M | 185.91M | 179.12M |
| Shares Outstanding (Diluted) | 229.49M | 218.58M | 206.70M | 192.20M | 185.91M | 179.12M |
| EPS (Basic) | -1.68 | 1.26 | -0.43 | -1.18 | -1.33 | -1.03 |
| EPS (Diluted) | -1.68 | 1.21 | -0.43 | -1.18 | -1.33 | -1.03 |
| Free Cash Flow | 373.38M | 344.90M | -53.14M | -97.31M | -163.20M | -144.54M |
| Free Cash Flow Per Share | 1.63 | 1.58 | -0.26 | -0.51 | -0.88 | -0.81 |
| Gross Margin | 77.39% | 79.06% | 58.80% | 34.68% | 4.04% | -37.48% |
| Operating Margin | 45.63% | 39.70% | -0.28% | -29.81% | -54.81% | -113.07% |
| Profit Margin | -40.90% | 30.16% | -19.72% | -68.36% | -91.25% | -117.11% |
| Free Cash Flow Margin | 39.70% | 39.42% | -11.79% | -29.36% | -60.26% | -91.97% |
| EBITDA | 433.05M | 350.79M | 1.73M | -95.91M | -146.18M | -176.83M |
| EBITDA Margin | 46.04% | 40.10% | 0.39% | -28.94% | -53.98% | -112.51% |
| D&A For EBITDA | 3.80M | 3.49M | 3.01M | 2.87M | 2.25M | 890.00K |
| EBIT | 429.25M | 347.30M | -1.28M | -98.78M | -148.44M | -177.72M |
| EBIT Margin | 45.63% | 39.70% | -0.28% | -29.81% | -54.81% | -113.07% |
| Effective Tax Rate | 1.32% | |||||
| Revenue as Reported | 940.61M | 874.84M | 450.71M | 331.41M | ||
| Advertising Expenses | 13.82M | 13.57M | 14.40M | 14.89M | 5.71M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 154.97M | 89.74M | 104.71M | 110.64M | 304.77M | 504.39M |
| Short-Term Investments | 197.60M | 185.01M | 216.14M | 278.34M | 119.54M | 3.21M |
| Cash & Short-Term Investments | 352.57M | 274.75M | 320.85M | 388.99M | 424.31M | 507.60M |
| Receivables | 110.76M | 106.82M | 79.07M | 56.95M | 50.60M | 29.41M |
| Inventory | 6.06M | 5.40M | 8.09M | 28.68M | 27.53M | 15.79M |
| Prepaid Expenses | 14.82M | 17.18M | 13.75M | 19.54M | 12.59M | 9.99M |
| Restricted Cash | 479.00K | 201.00K | 210.00K | 1.80M | 1.47M | 3.35M |
| Total Current Assets | 484.68M | 404.35M | 421.97M | 495.97M | 516.50M | 566.14M |
| Property, Plant & Equipment | 21.67M | 18.99M | 19.79M | 20.91M | 15.42M | 15.19M |
| Long-Term Investments | 61.16M | 20.32M | 18.08M | 6.83M | ||
| Other Long-Term Assets | 51.50M | 29.66M | 28.34M | 80.00K | ||
| Total Assets | 557.85M | 514.16M | 490.42M | 516.96M | 550.00M | 588.15M |
| Accounts Payable | 11.46M | 15.83M | 11.64M | 20.89M | 14.36M | 27.81M |
| Accrued Expenses | 121.89M | 126.41M | 113.29M | 102.88M | 87.56M | 72.67M |
| Current Portion of Long-Term Debt | 43.81M | 38.45M | 32.68M | 23.57M | ||
| Current Portion of Leases | 3.00M | 1.63M | 2.77M | 2.65M | 2.37M | 1.82M |
| Current Unearned Revenue | 12.32M | 1.22M | 1.42M | |||
| Other Current Liabilities | 16.36M | 13.74M | ||||
| Total Current Liabilities | 208.85M | 196.07M | 160.38M | 149.99M | 105.51M | 103.72M |
| Long-Term Debt | 778.38M | 427.23M | 795.92M | 811.26M | 733.28M | 585.46M |
| Long-Term Leases | 11.45M | 10.01M | 10.05M | 11.23M | 5.80M | 5.96M |
| Long-Term Unearned Revenue | 13.46M | |||||
| Total Liabilities | 1.01B | 633.31M | 966.35M | 972.49M | 844.60M | 695.14M |
| Common Stock | 2.55M | 2.13M | 2.08M | 2.06M | 1.88M | 1.84M |
| Additional Paid-In Capital | 1.69B | 1.38B | 1.29B | 1.22B | 1.16B | 1.10B |
| Retained Earnings | -2.15B | -1.51B | -1.77B | -1.68B | -1.45B | -1.21B |
| Comprehensive Income & Other | -528.00K | 38.00K | 921.00K | 1.34M | 26.00K | 177.00K |
| Shareholders' Equity | -454.29M | -119.15M | -475.93M | -455.53M | -294.60M | -106.99M |
| Total Liabilities & Equity | 557.85M | 514.16M | 490.42M | 516.96M | 550.00M | 588.15M |
| Total Debt | 836.64M | 477.33M | 841.42M | 848.71M | 741.45M | 593.24M |
| Net Cash (Debt) | -484.07M | -202.58M | -520.57M | -459.73M | -317.14M | -85.64M |
| Net Cash Per Share | -2.11 | -0.93 | -2.52 | -2.39 | -1.71 | -0.48 |
| Filing Date Shares Outstanding | 255.54M | 250.80M | 208.96M | 206.15M | 188.45M | 184.66M |
| Total Common Shares Outstanding | 255.26M | 213.06M | 208.54M | 205.77M | 187.91M | 184.35M |
| Working Capital | 275.84M | 208.28M | 261.58M | 345.98M | 410.99M | 462.42M |
| Book Value Per Share | -1.78 | -0.56 | -2.28 | -2.21 | -1.57 | -0.58 |
| Tangible Book Value | -454.29M | -119.15M | -475.93M | -455.53M | -294.60M | -106.99M |
| Tangible Book Value Per Share | -1.78 | -0.56 | -2.28 | -2.21 | -1.57 | -0.58 |
| Machinery | 7.41M | 8.41M | 7.66M | 6.53M | 5.84M | |
| Construction In Progress | 97.00K | |||||
| Leasehold Improvements | 10.44M | 10.36M | 10.21M | 10.14M | 9.83M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -384.67M | 263.86M | -88.88M | -226.54M | -247.12M | -184.06M |
| Depreciation & Amortization | 3.80M | 3.49M | 3.01M | 2.87M | 2.25M | 890.00K |
| Other Amortization | -651.00K | |||||
| Loss (Gain) From Sale of Assets | -4.12M | -4.12M | ||||
| Asset Writedown & Restructuring Costs | 698.36M | 1.55M | ||||
| Loss (Gain) From Sale of Investments | -1.96M | -4.33M | -11.47M | -10.26M | -1.78M | -2.00K |
| Loss (Gain) on Equity Investments | 17.55M | 17.55M | ||||
| Stock-Based Compensation | 73.11M | 85.07M | 65.41M | 55.62M | 44.70M | 34.64M |
| Other Operating Activities | 46.37M | 42.75M | 67.19M | 114.03M | 99.03M | -1.75M |
| Change in Accounts Receivable | -17.47M | -36.81M | -22.70M | -6.09M | -21.47M | -20.82M |
| Change in Inventory | -11.40M | -1.64M | -4.16M | -1.45M | -12.42M | -8.77M |
| Change in Accounts Payable | 4.61M | 57.80M | 14.78M | 12.53M | -22.36M | 39.41M |
| Change in Unearned Revenue | 10.79M | -1.23M | -109.00K | 1.28M | ||
| Change in Other Net Operating Assets | -58.19M | -76.25M | -75.20M | -36.16M | -2.58M | -2.99M |
| Operating Cash Flow | 376.13M | 347.37M | -52.02M | -95.14M | -161.85M | -142.16M |
| Capital Expenditures | -2.76M | -2.47M | -1.12M | -2.17M | -1.35M | -2.38M |
| Sale of Property, Plant & Equipment | 550.00K | 550.00K | ||||
| Divestitures | -6.18M | -6.18M | ||||
| Investment in Securities | 49.16M | -5.59M | 53.72M | -129.33M | -126.89M | 18.19M |
| Investing Cash Flow | -448.71M | -13.69M | 52.59M | -131.50M | -128.24M | 15.80M |
| Long-Term Debt Issued | 300.00M | 73.07M | 293.87M | |||
| Long-Term Debt Repaid | -334.76M | -1.70M | -262.88M | |||
| Net Debt Issued (Repaid) | 127.48M | -334.76M | -1.70M | 37.12M | 73.07M | 293.87M |
| Issuance of Common Stock | 29.11M | 9.17M | 3.48M | 8.68M | 14.96M | 65.79M |
| Repurchase of Common Stock | -11.51M | -8.85M | -7.54M | -2.17M | ||
| Other Financing Activities | -20.45M | -15.50M | -11.15M | |||
| Financing Cash Flow | 124.62M | -349.93M | -5.76M | 32.48M | 88.03M | 359.67M |
| Foreign Exchange Rate Adjustments | -647.00K | 1.27M | -936.00K | 362.00K | 566.00K | 71.00K |
| Net Cash Flow | 66.46M | -14.99M | -6.12M | -193.79M | -201.50M | 233.39M |
| Free Cash Flow | 373.38M | 344.90M | -53.14M | -97.31M | -163.20M | -144.54M |
| Free Cash Flow Margin | 39.70% | 39.42% | -11.79% | -29.36% | -60.26% | -91.97% |
| Free Cash Flow Per Share | 1.63 | 1.58 | -0.26 | -0.51 | -0.88 | -0.81 |
| Levered Free Cash Flow | 323.67M | 256.42M | 11.95M | -67.23M | -141.51M | -122.67M |
| Unlevered Free Cash Flow | 370.72M | 305.72M | 73.52M | 416.88K | -79.58M | -85.61M |
| Cash Interest Paid | 21.43M | 23.73M | 30.38M | 22.14M | 900.00K | |
| Cash Income Tax Paid | 4.63M | 2.80M | 1.60M | 1.43M | 3.54M | 118.00K |
| Change in Working Capital | -71.66M | -56.90M | -87.28M | -32.40M | -58.95M | 8.12M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.16B | 1.64B | 1.56B | 1.23B | 2.14B | 2.49B |
| Enterprise Value | 2.65B | 2.11B | 2.07B | 1.67B | 2.44B | 2.60B |
| Last Close Price | 8.47 | 7.80 | 7.52 | 5.99 | 11.48 | 13.85 |
| PE Ratio | 6.22 | |||||
| Forward PE | 16.33 | 33.02 | ||||
| PS Ratio | 2.30 | 1.88 | 3.46 | 3.70 | 7.90 | 15.86 |
| PB Ratio | -13.78 | -3.27 | -2.69 | -7.26 | -23.29 | |
| P/FCF Ratio | 5.80 | 4.76 | ||||
| P/OCF Ratio | 5.75 | 4.73 | ||||
| EV/Sales Ratio | 2.82 | 2.42 | 4.59 | 5.05 | 8.99 | 16.56 |
| EV/EBITDA Ratio | 6.12 | 6.02 | 1,194.32 | |||
| EV/EBIT Ratio | 6.17 | 6.08 | ||||
| EV/FCF Ratio | 7.09 | 6.12 | ||||
| Debt / Equity Ratio | -1.84 | -4.01 | -1.77 | -1.86 | -2.52 | -5.54 |
| Debt / EBITDA Ratio | 1.92 | 1.35 | 208.58 | |||
| Debt / FCF Ratio | 2.24 | 1.38 | ||||
| Net Debt / Equity Ratio | -1.07 | -1.70 | -1.09 | -1.01 | -1.08 | -0.80 |
| Net Debt / EBITDA Ratio | 1.12 | 0.58 | 300.38 | -4.79 | -2.17 | -0.48 |
| Net Debt / FCF Ratio | 1.30 | 0.59 | -9.79 | -4.72 | -1.94 | -0.59 |
| Asset Turnover | 1.85 | 1.74 | 0.90 | 0.62 | 0.48 | 0.34 |
| Inventory Turnover | 38.32 | 27.16 | 10.10 | 7.70 | 12.00 | 18.93 |
| Quick Ratio | 2.22 | 1.95 | 2.49 | 2.97 | 4.50 | 5.18 |
| Current Ratio | 2.32 | 2.06 | 2.63 | 3.31 | 4.89 | 5.46 |
| Return on Assets (ROA) | 52.86% | 43.21% | -0.16% | -11.57% | -16.30% | -24.07% |
| Return on Invested Capital (ROIC) | 138.77% | 105.76% | -0.37% | -24.35% | -31.96% | -49.82% |
| Return on Capital Employed (ROCE) | 123.00% | 109.20% | -0.40% | -26.90% | -33.40% | -36.70% |
| Earnings Yield | -19.79% | 16.07% | -5.71% | -18.47% | -11.55% | -7.39% |
| FCF Yield | 17.25% | 21.00% | -3.41% | -7.93% | -7.63% | -5.80% |
| Buyback Yield / Dilution | -10.24% | -5.75% | -7.54% | -3.38% | -3.79% | -7.08% |